Kudo-Saito C - Search Results

1

Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells: implications for intratumoral vaccine therapy.

Slavin-Chiorini DC, Catalfamo M, Kudo-Saito C, Hodge JW, Schlom J, Sabzevari H. Slavin-Chiorini DC, et al. Cancer Gene Ther. 2004 Oct;11(10):665-80. doi: 10.1038/sj.cgt.7700741. Cancer Gene Ther. 2004. PMID: 15354200

2

Intratumoral vaccination and diversified subcutaneous/ intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory molecules.

Kudo-Saito C, Schlom J, Hodge JW. Kudo-Saito C, et al. Clin Cancer Res. 2004 Feb 1;10(3):1090-9. doi: 10.1158/1078-0432.ccr-03-0145. Clin Cancer Res. 2004. PMID: 14871989

3

Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.

Kudo-Saito C, Schlom J, Hodge JW. Kudo-Saito C, et al. Clin Cancer Res. 2005 Mar 15;11(6):2416-26. doi: 10.1158/1078-0432.CCR-04-1380. Clin Cancer Res. 2005. PMID: 15788693

4

Multiple costimulatory modalities enhance CTL avidity.

Hodge JW, Chakraborty M, Kudo-Saito C, Garnett CT, Schlom J. Hodge JW, et al. J Immunol. 2005 May 15;174(10):5994-6004. doi: 10.4049/jimmunol.174.10.5994. J Immunol. 2005. PMID: 15879092 Free PMC article.

5

The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors.

Kudo-Saito C, Schlom J, Camphausen K, Coleman CN, Hodge JW. Kudo-Saito C, et al. Clin Cancer Res. 2005 Jun 15;11(12):4533-44. doi: 10.1158/1078-0432.CCR-04-2237. Clin Cancer Res. 2005. PMID: 15958639

6

Costimulatory molecules as adjuvants for immunotherapy.

Hodge JW, Greiner JW, Tsang KY, Sabzevari H, Kudo-Saito C, Grosenbach DW, Gulley JL, Arlen PM, Marshall JL, Panicali D, Schlom J. Hodge JW, et al. Front Biosci. 2006 Jan 1;11:788-803. doi: 10.2741/1837. Front Biosci. 2006. PMID: 16146771 Review.

7

TRICOM vector based cancer vaccines.

Garnett CT, Greiner JW, Tsang KY, Kudo-Saito C, Grosenbach DW, Chakraborty M, Gulley JL, Arlen PM, Schlom J, Hodge JW. Garnett CT, et al. Curr Pharm Des. 2006;12(3):351-61. doi: 10.2174/138161206775201929. Curr Pharm Des. 2006. PMID: 16454749 Review.

8

4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines.

Kudo-Saito C, Hodge JW, Kwak H, Kim-Schulze S, Schlom J, Kaufman HL. Kudo-Saito C, et al. Vaccine. 2006 Jun 5;24(23):4975-86. doi: 10.1016/j.vaccine.2006.03.042. Epub 2006 Mar 31. Vaccine. 2006. PMID: 16621183 Free PMC article.

9

Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2.

Kudo-Saito C, Wansley EK, Gruys ME, Wiltrout R, Schlom J, Hodge JW. Kudo-Saito C, et al. Clin Cancer Res. 2007 Mar 15;13(6):1936-46. doi: 10.1158/1078-0432.CCR-06-2398. Clin Cancer Res. 2007. PMID: 17363550

10

Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activity.

Kudo-Saito C, Garnett CT, Wansley EK, Schlom J, Hodge JW. Kudo-Saito C, et al. Cancer Immunol Immunother. 2007 Dec;56(12):1897-910. doi: 10.1007/s00262-007-0332-1. Epub 2007 May 15. Cancer Immunol Immunother. 2007. PMID: 17503041 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page